# Haplotype‐Based Analysis of OCA2 Variants in Oculocutaneous Albinism

**Authors:** Meredith F. Gillis, Madeleine R. Ames, Linnea Lundh, Valer Gotea, Laura Elnitski, Frank Donovan, Adebowale Adeyemo, Charles Rotimi, Brian Brooks, Wadih Zein, William Gahl, William S. Oetting, David R. Adams, Stacie K. Loftus

PMC · DOI: 10.1111/pcmr.70085 · 2026-03-29

## TL;DR

This study examines how combinations of rare and common genetic variants in the OCA2 gene affect oculocutaneous albinism type 2 and skin/eye pigmentation.

## Contribution

The study introduces haplotype-based analysis combining rare disease variants with common regulatory variants in OCA2.

## Key findings

- 41 distinct multi-allele OCA2 haplotypes were identified in 95 out of 106 OCA2 probands.
- Common GWAS alleles that reduce splicing or gene expression co-occur with rare variants of unknown significance on haplotypes.
- Haplotype-based analysis is essential for understanding OCA2-related phenotypic diversity and variant pathogenicity.

## Abstract

OCA2, a melanosome transmembrane spanning protein, functions to regulate melanosomal pH, optimizing production of melanin pigment. OCA2 is one of eight non‐syndromic autosomal recessive oculocutaneous albinism (OCA) loci and is the second most common cause of OCA worldwide. Genome wide association studies (GWAS) have identified OCA2 coding and regulatory variants linked to common skin and eye color pigment variation, skin cancer susceptibility, and retinal pigment epithelium tissue metrics. Within a cohort of 106 OCA2 probands with two biallelic OCA2 variants, a total of 74 distinct OCA2 rare variants were identified (11 large structural, 17 small indel/frameshift, 12 splice site, and 34 missense coding variants). Phase‐validated haplotypes, comprised of both OCA2 common pigmentation trait GWAS alleles and rare variants, were obtained for 95/106 probands. In total, 41 distinct multi‐allele OCA2 haplotypes were identified with 27 haplotypes containing either rs1800404‐A and/or rs12913832‐G alleles, each of which is known to reduce correct isoform splicing or gene expression by ~20%. These results find that common GWAS alleles with known OCA2 functional impact are present on haplotypes with variants of unknown significance in OCA2 probands and highlight the need for haplotype‐based analysis at the OCA2 locus in addition to individual variant pathogenic assessment.

This work evaluates the pathogenicity of rare OCA2 variants from 106 OCA type 2 individuals. The identified pigmentation trait associated, multivariant haplotypes have implications in understanding the phenotypic diversity associated with OCA type 2.

This study defines multi‐allele haplotypes, comprised of rare disease variants combined with common eQTL, sQTL and GWAS variants, for oculocutaneous albinism type 2 (OCA2). These haplotypes have implications for variant pathogenicity assessments and phenotypic variability.

## Linked entities

- **Genes:** OCA2 (OCA2 melanosomal transmembrane protein) [NCBI Gene 4948]
- **Diseases:** oculocutaneous albinism (MONDO:0018910), OCA2 (MONDO:0008746)

## Full-text entities

- **Genes:** TYRP1 (tyrosinase related protein 1) [NCBI Gene 7306] {aka CAS2, CATB, GP75, OCA3, TRP, TRP1}, SLC45A2 (solute carrier family 45 member 2) [NCBI Gene 51151] {aka 1A1, AIM1, MATP, OCA4, SHEP5}, MC1R (melanocortin 1 receptor) [NCBI Gene 4157] {aka CMM5, MSH-R, SHEP2}, DCT (dopachrome tautomerase) [NCBI Gene 1638] {aka OCA8, TRP-2, TYRP2}, SLC24A5 (solute carrier family 24 member 5) [NCBI Gene 283652] {aka JSX, NCKX5, OCA6, SHEP4}, AP3B1 (adaptor related protein complex 3 subunit beta 1) [NCBI Gene 8546] {aka ADTB3, ADTB3A, HPS, HPS2, PE}, OCA2 (OCA2 melanosomal transmembrane protein) [NCBI Gene 4948] {aka BEY, BEY1, BEY2, BOCA, D15S12, EYCL}, LYST (lysosomal trafficking regulator) [NCBI Gene 1130] {aka CHS, CHS1, Mauve}, HERC2 (HECT and RLD domain containing E3 ubiquitin protein ligase 2) [NCBI Gene 8924] {aka D15F37S1, MRT38, SHEP1, jdf2, p528}, MFSD12 (major facilitator superfamily domain containing 12) [NCBI Gene 126321] {aka C19orf28, PP3501, SLC59B1}, HPS6 (HPS6 biogenesis of lysosomal organelles complex 2 subunit 3) [NCBI Gene 79803] {aka BLOC2S3}
- **Diseases:** traits (MESH:C567520), foveal hypoplasia (MESH:C537858), VUS (MESH:D009382), skin cancer (MESH:D012878), OCA type 1B (MESH:C537729), Hypopigmentation of the skin (MESH:D017496), OCA (MESH:D016115), albinism (MESH:D000417), NC_000015.10 (OMIM:617025), melanoma (MESH:D008545), CCS (MESH:D010855), autosomal recessive disorder (MESH:D030342), OCA type 8 (MESH:C537728), pigmentation (MESH:D010859), OCA type 2 (MESH:C537730)
- **Chemicals:** chloride (MESH:D002712), -Q04671-F1 (-), sterol (MESH:D013261), melanin (MESH:D008543), TPM (MESH:D000077236)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** g.27844884_28020885del, 2201 T>G, p.Leu207_Leu212del, Leu440Phe, p.Asn489Asp, c.1555delG, c.2195C>T, 5G>C, p.Ser641Leu, c.1262-1_1264dup, c.1025A>G, c.757G>A, p.Pro211Ala, Phe292Leu, p.Gln310Ter, c.1901T>A, A>G, p.Val792del, c.493C>T, c.1095_1103del, c.228-2A>G, p.Pro743Leu, 1211C>T, p.Arg419Trp, 1465A>G, 406C>T, g.27979571_27984604del, 2180T>C, c.1065G>A, 401G>A, c.1365-1G>C, p.Val433Ile, p.Ala368Val, 1076G>A, c.2037G>C, 1G>A, p.Ser92fs*10, c.632C>T, g.27874777_28094256delins, c.1636G>A, G>A, Glu253Lys, p.Leu674Val, c.1116+5A, 25617295_25801161del, g.28017719_28020678delinsTTT, c.2370_2375delinsCGT, 2324G>A, c.2359G>A, 2207C>T, 1320G>C, p.Ala355=, c.1922C>T, p.Trp204Ter, 1897G>A, c.819_822delinsGGTC, Arg402Gln, p.Glu546Lys, 889 T>A, c.1239+5G>C
- **Cell lines:** MNT-1 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_5624)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13033472/full.md

---
Source: https://tomesphere.com/paper/PMC13033472